XML 47 R37.htm IDEA: XBRL DOCUMENT v3.8.0.1
Other impairments, restructuring and other items (Tables)
3 Months Ended
Mar. 31, 2018
Summary of other impairments, restructuring and other items

Other impairments, restructuring and other items consisted of the following:

 

     Three months ended
March 31,
 
     2018      2017  
     (U.S. $ in millions)  

Restructuring expenses

   $ 247      $ 130  

Integration expenses

     —          23  

Contingent consideration

     8        21  

Impairments of long-lived assets

     432        11  

Other

     20        55  
  

 

 

    

 

 

 

Total

   $ 707      $ 240  
  

 

 

    

 

 

 
Components of costs associated with restructuring plan including costs related to exit and disposal activities

The following table provides the components of costs associated with Teva’s restructuring plan including costs related to exit and disposal activities:

 

     Three months ended March 31,  
     2018      2017  
     (U.S. $ in millions)  

Restructuring

     

Employee termination

   $ 228      $ 95  

Other

     19        35  
  

 

 

    

 

 

 

Total

   $ 247      $ 130  
  

 

 

    

 

 

 
Components of and Changes in Company's Restructuring Accruals

The following table provides the components of and changes in the Company’s restructuring accruals:

 

     Employee termination
costs
     Other      Total  
     (U.S. $ in millions )  

Balance as of January 1, 2018

   $ (294    $ (17    $ (311

Provision

     (228      (19      (247

Utilization and other*

     129        7        136  
  

 

 

    

 

 

    

 

 

 

Balance as of March 31, 2018

   $ (393    $ (29    $ (422
  

 

 

    

 

 

    

 

 

 
* Includes adjustments for foreign currency translation.